Recent advances in the molecular signaling pathways of Substance P in Alzheimer's disease: Link to neuroinflammation associated with toll-like receptors

被引:3
|
作者
Gurram, Prasada Chowdari [1 ,2 ]
Satarker, Sairaj [1 ]
Nampoothiri, Madhavan [1 ]
机构
[1] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmacol, Manipal 576104, Karnataka, India
[2] Koneru Lakshmaiah Educ Fdn, KL Coll Pharm, Vaddeswaram 522302, AP, India
关键词
Substance P; Alzheimer's disease; TLR; Neurokinin; Neurodegeneration; Neuroinflammation; AMYLOID PRECURSOR PROTEIN; MESSENGER-RNA EXPRESSION; NEUROKININ-1; RECEPTOR; IMMUNE-SYSTEM; TACHYKININS; CELLS; PEPTIDE; IMMUNOREACTIVITY; INTERLEUKIN-6; MODULATION;
D O I
10.1016/j.bbrc.2024.150597
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A significant quantity of substance P (SP) and its receptor, the neurokinin 1 (NK1) receptors are found in the brain. SP is a neuropeptide distributed in the central nervous system and functions as a neurotransmitter, neuromodulator, and neurotrophic factor. The concentrations of SP in the brain and cerebrospinal fluid fluctuate in individuals with Alzheimer's disease (AD). SP is an endogenous ligand for NK1 receptor, enhancing the expression of toll-like receptors (TLR) and vice versa. So, both pathways are interconnected, where activation of one pathway activates the second pathway. Researchers have observed the interaction of TLR with SP in the pathophysiology of AD. Thus, this review discusses various TLRs involved in regulating amyloid processing and its interaction with SP in AD. Further, in AD pathology, SP can regulate the non-amyloidogenic pathway. Recent studies have also demonstrated the capacity of SP in regulating voltage-gated potassium channel currents, emphasizing SP's neuroprotective ability. Therefore, we corroborate the findings linking the SP, NK1R, and TLRs in AD.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Toll-like receptors in Alzheimer's disease
    Momtazmanesh, Sara
    Perry, George
    Rezaei, Nima
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 348
  • [2] Toll-Like Receptors in Alzheimer's Disease
    Landreth, Gary E.
    Reed-Geaghan, Erin G.
    TOLL-LIKE RECEPTORS: ROLES IN INFECTION AND NEUROPATHOLOGY, 2009, 336 : 137 - 153
  • [3] Renal Toll-like receptors: recent advances and implications for disease
    El-Achkar, Tarek M.
    Dagher, Pierre C.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (10): : 568 - 581
  • [4] Renal Toll-like receptors: recent advances and implications for disease
    Tarek M El-Achkar
    Pierre C Dagher
    Nature Clinical Practice Nephrology, 2006, 2 : 568 - 581
  • [5] The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
    Arash Heidari
    Niloufar Yazdanpanah
    Nima Rezaei
    Journal of Neuroinflammation, 19
  • [6] The role of Toll-like receptors and neuroinflammation in Parkinson's disease
    Heidari, Arash
    Yazdanpanah, Niloufar
    Rezaei, Nima
    JOURNAL OF NEUROINFLAMMATION, 2022, 19 (01)
  • [7] Microglial toll-like receptors and Alzheimer's disease
    Su, Fan
    Bai, Feng
    Zhou, Hong
    Zhang, Zhijun
    BRAIN BEHAVIOR AND IMMUNITY, 2016, 52 : 187 - 198
  • [8] Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease
    Dhapola, Rishika
    Hota, Subhendu Shekhar
    Sarma, Phulen
    Bhattacharyya, Anusuya
    Medhi, Bikash
    Reddy, Dibbanti HariKrishna
    INFLAMMOPHARMACOLOGY, 2021, 29 (06) : 1669 - 1681
  • [9] Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
    Rishika Dhapola
    Subhendu Shekhar Hota
    Phulen Sarma
    Anusuya Bhattacharyya
    Bikash Medhi
    Dibbanti HariKrishna Reddy
    Inflammopharmacology, 2021, 29 : 1669 - 1681
  • [10] Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis
    Rahmani, Farzaneh
    Rezaei, Nima
    Expert Review of Clinical Immunology, 2016, 12 (12) : 1289 - 1298